Shreyasi Majumdar

Dr. Shreyasi Majumdar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Neurochemistry International
Verified
Journal Article
Closed access
SMShreyasi Majumdar
Shreyasi Majumdar
SGSmriti Gupta
Smriti Gupta
Santosh Kumar PrajapatiSantosh Kumar Prajapati
Santosh Kumar Prajapati
SKSairam Krishnamurthy
Sairam Krishnamurthy

8 October 2021 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
SMShreyasi Majumdar
Shreyasi Majumdar
SGSmriti Gupta
Smriti Gupta
SKSairam Krishnamurthy
Sairam Krishnamurthy
Bioactive glasses are the third generation biomaterial exhibiting soft tissue regenerative properties. They promote vascularization of the tissue-engineered construct required for tissue regeneration without posing significant adverse effects.

11 August 2022 in Ceramics International
Verified
Journal Article
Closed access
SMShreyasi Majumdar
Shreyasi Majumdar
SKSairam Krishnamurthy
Sairam Krishnamurthy

4 February 2026 in Cells
Verified
Journal Article
Open access
PDF file
SMShreyasi Majumdar
Shreyasi Majumdar
Santosh Kumar PrajapatiSantosh Kumar Prajapati
Santosh Kumar Prajapati
DADande Aishwarya
Dande Aishwarya
VYVinod Kumar Yata
Vinod Kumar Yata
KCKhushboo Choudhary
Khushboo Choudhary
SKSairam Krishnamurthy
Sairam Krishnamurthy
Neuropathic pain (NP) arises from maladaptive changes in peripheral and central nociceptive circuits, yet molecular alterations spanning the entire pain neuraxis remain poorly understood. Neuroinflammation is increasingly recognized as a central mechanism in NP chronification, yet the region-specific molecular events linking immune activation to affective pain processing remain inadequately defined. In this study, we employed high-resolution LC-HRMS-based quantitative proteomics to investigate chronic constriction injury (CCI)-induced molecular alterations in the sciatic nerve (SN), spinal cord (SC), and orbitofrontal cortex (OFC) of male Wistar rats, a region critical for affective and cognitive pain modulation. Behavioral assessments confirmed the development of NP phenotypes and motor deficits. Proteomic profiling revealed exclusive and differentially expressed proteins enriched in neuroinflammatory pathways across all regions. S100 proteins (S100A8 and S100B) were significantly elevated in SN, SC, and OFC, as confirmed by immunofluorescence. Their up-regulation coincided with increased astrocyte (GFAP) and microglial (Iba-1) activation, highlighting a pervasive inflammatory milieu. Intriguingly, the OFC proteome demonstrated marked up-regulation of dopamine-regulating proteins and positive regulation of dopaminergic neurotransmission, suggesting involvement of reward-related analgesic circuits. Together, our findings delineate a “nociceptive neuraxis” driven by neuroimmune activation and neuromodulatory adaptations that interfaces with dopaminergic signaling to influence sensory and affective components of pain. This integrative molecular map highlights potential therapeutic targets, including glial-derived S100 proteins and dopamine modulators for the comprehensive management of NP.

14 May 2025 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
RMRangan Mitra
Rangan Mitra
SKSandeep Kumar
Sandeep Kumar
ACAISWARYA CHAUDHURI
AISWARYA CHAUDHURI
SMShreyasi Majumdar
Shreyasi Majumdar
SKSairam Krishnamurthy
Sairam Krishnamurthy
SASenthil Raja Ayyannan
Senthil Raja Ayyannan

26 March 2026
Verified
Book Chapter
Closed access
SMShreyasi Majumdar
Shreyasi Majumdar
PSPuneet K. Samaiya
Puneet K. Samaiya
Santosh Kumar PrajapatiSantosh Kumar Prajapati
Santosh Kumar Prajapati